A new galectin was characterized in the Amethyst deceiver mushroom Laccaria amethystina. The complete amino acid (AA) sequence of the lectin, which exhibited -galactoside specificity, was deduced from its peptide sequences. The AA sequence of L. amethystina galectin (LAG) showed high homology with those of the same genus, at 75.6% identity to Laccaria bicolor, and 35.5-65.0% to galectins of Agrocybe spp. and Coprinopsis cinerea. The AA sequence of LAG contained all but one conserved residue known to be involved in -galactoside binding, with His at the position 57 residue replaced by Thr in LAG. Analysis of binding specificity by hemagglutination inhibition assay and enzyme-linked lectinsorbent assay revealed high specificity of LAG towards O-glycoproteins.
It plays various roles in forest ecosystems, supplying mineral nutrients that are absorbed by extrametrical mycelia to the host, and receives photosynthetic products in return. Guillot et al.
2) have isolated two lectins of different specificity: LAL, specific to lactose, and LAF, specific to fucose. Of these two lectins, LAL was more abundant, and it agglutinates human A and O type erythrocytes, but the protein characteristics of these lectins have not been clarified yet. The present study was conducted to elucidate the primary structure and sugar binding specificity of L. amethystina lectin, and to determine its applicability in glyco-biological research.
Members of the galectin family are defined by a shared consensus of about 130 amino acids and the carbohydrate recognition domain (CRD) responsible for beta-galactoside binding. 3) To date only four galectins and one galectin-related protein of mushrooms have been characterized. [4] [5] [6] [7] Laccaria is a cosmopolitan genus comprising about 30 species of fungal mushrooms found both in temperate and tropical regions of the world. 8) The Laccaria species are a major experimental model of ectomycorrhizal symbiotic research, but information on the detection, isolation, purification, and characterization of the proteins in this genus is relatively limited. The lectin in mushrooms of genus Laccaria was first detected in L. amethystina, 9) and then in Laccaria laccata. 10) The genomic DNAs of Laccaria bicolor galectins were sequenced, 11) but they were not characterized as proteins. Information on galectin is not available except for these sequences.
The present report introduces one member of the galectin family of L. amethystina, herein referred to as LAG.
Materials and Methods
Materials. Samples of the L. amethystina mushroom were collected in spring and autumn in the coastal pines forests of Fukiage Beach, in 2005 through 2008. The samples were lyophilized and stored at À20 C prior to analysis. The sugars and glycoproteins used for inhibition studies were purchased from Sigma-Aldrich (St. Louis, MO), except for blood group A trisaccharides, 3-fucosyllactose, and 2 0 -fucosyllactose were from Dextra Laboratories (Reading, UK).
Purification of lectin. All purification procedures were carried out at 4 C. The protein was extracted by homogenization of the ground mushroom with a 20-fold volume of phosphate-buffered saline (PBS), pH 7.2, for 1 h. The resulting supernatant was filtered and centrifuged at 12;000 Â g for 20 min to remove insoluble residues. Solid (NH 4 ) 2 SO 4 was added to the supernatant to 100% saturation, and this was left to stand overnight. The precipitate was collected by centrifugation at 18;000 Â g for 20 min, and then dissolved in PBS. The clear crude extract obtained was loaded onto a bovine submaxillary mucin (BSM)-formyl cellulofine column equilibrated with PBS. Unbound protein was washed with PBS, and the adsorbed lectin was then eluted with 200 mM lactose in PBS.
Hemagglutination activity of L. amethystina galectin. Hemagglutination activity was assayed by 2-fold serial dilution of 50 mL in microtiter plate wells to a final volume of 70 mL by the addition of 20 mL of 4% (by vol.) suspension of washed human erythrocytes (types O, A, B) and rabbit erythrocytes. The samples were incubated for 1 h at room temperature, and the lowest concentration of lectin required to y To whom correspondence should be addressed. Tel/Fax: +81-99-285-8631; E-mail: fyagi@chem.agri.kagoshima-u.ac.jp Abbreviations: AAL, Agrocybe aegerita lectin; ACG, Agrocybe cylindracea galectin; BSM, bovine submaxillary mucin; CCG1-3, Coprinus cinereus galectin1-3; ELLSA, enzyme linked lectin-sorbent assay; HPLC, high performance liquid chromatography; LBG1-3, Laccaria bicolor galectin 1-3; MALDI-TOFMS, matrix-assisted laser desorption/ionization-time of flight mass spectrometry; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; PNP, p-nitrophenyl; PSM, porcine stomach mucin agglutinate red blood cells was determined visually. The hemagglutination titer was defined as the reciprocal of the highest dilution exhibiting hemagglutination. Specific activity was then defined as titer per mg of protein.
Inhibition of hemagglutination by lectin was assayed with trypsinized rabbit erythrocytes in the presence of saccharides and glycoproteins as inhibitors. The tested saccharides and glycoprotein were 2-fold diluted in PBS and mixed with equal volumes of lectin solution (4 hemagglutination units). The mixtures were allowed to stand for 30 min at room temperature, and a 4% trypsinized rabbit erythrocyte suspension was added. Inhibition of agglutination was examined after 1 h of incubation. Inhibitory potency was then expressed as the reciprocal of the minimum concentration of each sugar or glycoprotein required to inhibit the hemagglutination activity of titer 2 of the lectin completely.
Enzyme linked lectin-sorbent assay (ELLSA) and inhibition assay. For ELLSA of the lectin, biotinylated LAG was used. The carboxylic acid groups of the lectin were biotinylated with biotin hydrazide (Dojindo, Kumamoto, Japan) following manufacturer's protocol and the resulting conjugate was extensively dialyzed with PBS, pH 7.2, and stored at 4 C. ELLSA was performed on 96-well F-bottomed microwell plates (Maxisorp, Nunc, Roskilde, Denmark) following the procedure described by Duk et al.
12) The volume of each reagent added to the plate was 50 mL/well, and all incubations (except for coating) were performed at 20 C. PBS containing 0.05% Tween 20 (PBS-T) was used to wash the microtiter wells between incubations. All the reagents were diluted with PBS-T, unless specified otherwise. The optimal detection limit of the ELLSA for biotinylated LAG was approximately 12.5 ng. The wells were coated with varying amounts of glycoproteins in 50 mM carbonate-bicarbonate buffer pH 9.6 at 4 C overnight. After washing of the plates, 12.5 ng/50 mL of biotinylated lectin was added to each well, and the mixture was incubated for 1 h. The plates were then washed, and avidin alkaline phosphatase solution (1:10,000, Sigma-Aldrich) added, and were then extensively washed again after 1 h of incubation. One mg/mL of p-nitrophenyl phosphate (Sigma-Aldrich) in 50 mM carbonate-bicarbonate buffer, pH 9.6 containing 1 mM MgCl 2 was added, and the mixture were incubated for 2 h. The absorbance was then read at 405 nm on a microtiter reader.
Finally, an inhibition study was done by mixing serially diluted glycoproteins and sugars with equal volumes of lectin solution containing 6.25 ng. The control lectin was 2-fold diluted. After 45 min of incubation, the samples were added to the wells of 250 ng asialo-fetuin coated micro titer plates and tested by the binding assay described above. Inhibitory activity was estimated from the inhibition curve, and was expressed as the amount of inhibitor causing 50% inhibition of control LAG binding. All the experiments were conducted in triplicate, and the results were expressed as mean values.
Estimation of protein concentration. The Lowry method 13) was used to estimate the protein content, with bovine serum albumin (BSA) as a standard.
Homogeneity and molecular weight determination. Native polyacrylamide gel electrophoresis (PAGE), 14) sodium dodecyl-sulfate (SDS)-PAGE, and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOFMS) were used to confirm the purity of LAG. SDS-PAGE was conducted by the procedure described by Laemmli, 15) using 15% polyacrylamide running gel. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250. The molecular mass of the purified LAG was determined by comparing it with standard molecular weight markers (wide range; Technical Frontier, Tokyo). MALDI-TOFMS was recorded in positive ion mode with Voyager DE-RP (Perseptive Biosystems, Boston, MA), and expressed as the average results of at least 100 laser shots. Sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) was used as the matrix. The molecular mass of LAG was also estimated by gel filtration on a Toyopearl HW55F column.
Amino acid composition. Amino acid analysis was done by the PICO-TAGÔ amino acid analysis system (Waters Millipore, Milford, MA). A sample of 200 mg of LAG and 50-100 mg of peptides were hydrolyzed under vacuum with 6 M HCl at 110 C in a sealed evacuated tube for 24 h. The hydrolysate was neutralized, derivatized, and then assessed by the PICO TAGÔ system.
Determination of the amino-terminal sequence. NH 2 -Terminal sequencing of LAG and peptides was performed on a Procise Model 492 Protein Sequencer (Perkin-Elmer Applied Biosystem Division, Foster, CA) attached to a model 140C PTH-amino acid analyzer (Perkin-Elmer Applied Biosystems, Tokyo).
Chemical cleavage of LAG. Chemical cleavage of the lectin was targeted to tryptophan residue with o-iodosobenzoic acid following Mahoney et al., 16) and to asparagine-glycine bonds with hydroxylamine, as described by Enfield et al. 17) Cleaved fragments were separated by tricine SDS-PAGE 18) and electroblotted onto a PVDF membrane by the method of Matsudaira.
19)
Enzymatic digestion of LAG. Enzymatic digestion of LAG was conducted as follows: Four hundred mg of LAG was dissolved in 0.1 M NH 4 HCO 3 at pH 8.1 and digested with trypsin (Wako Pure Chemical, Osaka, Japan) at 37
C for 4 h. The enzyme to substrate ratio was 1:50 w/w. Cleavage with thermolysin (Wako Pure Chemical) was performed at an enzyme to substrate ratio of 1:50 w/w at 37 C for 2 h. Cleavage with chymotrypsin (Sigma-Aldrich) was conducted at an enzyme to substrate ratio of 1:50 w/w in 0.1 M NH 4 HCO 3 , pH 8.1 at 37
C for 2 h. Endoproteinase Asp-N (Takara Bio, Ohtsu, Japan) was used to hydrolyze the peptides after chemical cleavage of methionine residue by CNBr. The peptides were dissolved in 50 mM sodium phosphate buffer, pH 8.0, and incubated at 37 C for 18 h at an enzyme to substrate ratio of 1:50 w/w.
Peptides purification. Peptides after enzyme digestion were separated by reverse-phase high performance liquid chromatography (RP-HPLC) on a Cosmosil 5C 4 column (4:6 Â 250 mm) AR 300 for tryptic peptides, and a Cosmosil 5C 18 column AR 300 (4:6 Â 250 mm) for thermolytic peptides. The samples were eluted at a flow rate of 0.8 mL/min using a linear gradient of 0-60% acetonitrile in 0.1% TFA, and the absorbance monitored at 230 nm. The peptides recovered were analyzed with a MALDI-TOFMS and sequencing was performed on the protein sequencer.
Genomic DNA sequence analysis. Genomic DNA of L. amethystina was isolated using a DNeasy plant Maxi-kit (Qiagen, Venlo, Netherlands) following the manufacturer's protocol, and the purity was maximized by phenol chloroform treatment. Templates (20 ng/50 mL) were amplified using two sets of degenerate primers designed from partial sequences of L. amethystina QLAQPFQA (residues 12-19), MNSLPA (residues 69-74), and AVTTYKAFA (residues 146-153). Amplification was performed in a Geneamp Ò PCR System 9700 (Applied Biosystems) for 30 cycles at 95 C for 15 s, 57 C for 30 s, and 72 C for 45 s. The unknown region was further amplified using an LA PCR in vitro cloning kit (Takara Bio) and thermal asymmetric interlaced (TAIL)-PCR. LA PCR was conducted following the manufacturer's protocols, as follows: Five mg of L. amethystina genomic DNA was briefly digested with PST I at 37 C for 3 h. The digested DNA was then ligated to a PST I Cassette. PCR toward the end of the sequence was done using cassette primer I and a primer designed from the specific primers of LAG ACCTCCGTCAACA-TCTTCAGTGCCC. The amplified product was then used as a template for second PCR with cassette primer II and internal primer GACATCCTCCTCACCATCAGCATCCG. The PCR towards the beginning of the sequence was performed in the same manner as towards the end, using reverse complementary primers GGTGTTGT-AGTCGATCAGGACC and AGTACCATTCTTCTGGATCCTCTTG. TAIL-PCR was carried out using a short arbitrary degenerate primer with the nested sequence specific primers used in LA PCR, by the method described by Liu and Whittier. 20) The amplified fragments from both LA and TAIL PCR were confirmed by gel electrophoresis.
Results
L. amethystina galectin (LAG) was purified by affinity chromatography using a BSM-formyl cellufine column as affinity absorbent after it showed affinity to BSM (Table 2) , and elution was achieved by the addition of 200 mM lactose in PBS. A column profile depicting the purification of LAG from L. amethystina by affinity chromatography is shown in Fig. 1 .
Purification of LAG from L. amethystina extracts using the BSM-formyl cellufine column was sufficient, with high recovery of pure lectin as calculated from hemagglutination activity. Pure lectin (1.5 mg) was obtained from 5 g of freeze-dried samples at a yield of 54%. LAG was purified 115-fold, showing specific activity of 81,000 titer/mg of protein. The purification results are summarized in Table 1 . The purified LAG was homogeneous on native and SDS-PAGE. Irrespective of treatment with 2-mercaptoethanol, a single band of 17 kDa was found. MALDI TOF mass spectrometry showed a main peak at m=z 17,589.55 Daltons (Fig. 2) . By gel filtration, native LAG was estimated to be 35 kDa, suggesting that LAG is a homodimer.
Carbohydrate binding specificity was estimated by inhibition of hemagglutination activity and saccharide inhibition of biotinylated LAG-asialo fetuin interaction. Table 2 shows the inhibition of hemagglutination activity of LAG. Lactose inhibited the hemagglutination activity of purified LAG, while N-acetyllactosamine was a poor inhibitor. The other saccharides tested were not inhibitory, and asialoPSM was the most potent inhibitor.
The ability of various sugar ligands to inhibit the binding of biotinylated LAG (6.25 ng) was measured by ELLSA. It was deduced that biotinylation occurred at carboxylic acid, but the hemagglutination activity of the modified LAG was the same as that of intact LAG. Inhibitory activity was expressed as the amount of inhibitor giving 50% inhibition of control LAG binding.
The inhibitory potencies of several tested saccharides are summarized in Table 3 . The binding of LAG with lactose was about 5-fold higher than with N-acetyllactosamine, and 3-fold higher than T-antigen (Fig. 3) . Human blood group A trisaccharide was the best inhibitor, about twice as active as lactose, whereas binding to galactose and N-acetylgalactosamine was An affinity chromatography column (1 Â 10 cm) was prepared by immobilizing BSM on formyl cellufine. Crude protein (290 mg) was applied to the column, which was prequilibrated with PBS. The unbound fraction was washed with PBS, and the bound fraction was eluted with 200 mM lactose in PBS at a flow rate of 20 mL/h. Samples were collected in fractions of 3 mL. , Absorbance at 280 nm; , Hemagglutination activity (titer). poor. In the hemagglutination inhibition of LAG, galactose and N-acetylgalactosamine were non-inhibitors at 100 mM. The overall binding-inhibition pattern of saccharides for LAG was as follows: GalNAc1-
The specificity of LAG with glycoproteins was elucidated by hemagglutination-inhibition assay, ELLSA, and inhibition assay. Table 2 summarizes the results of hemagglutination inhibition of titer 2 of LAG. AsialoPSM O-linked glycoprotein was the most potent inhibitor of the glycoproteins tested, followed by PSM, asialoBSM, BSM, and human glycophorin A. N-linked glycoproteins transferrin, bovine thyroglobulin, porcine thyroglobulin, fetuin, 1-acid glycoprotein, and hen ovomucoid did not show inhibition up to 1 mg/mL, while asialofetuin partially inhibited the activity of LAG. Table 4 summarizes the interaction of LAG with immobilized glycoproteins, and the binding profiles are shown in Fig. 4 .
Results were expressed as quantity of glycoproteins (ng) required to yield 1.5 units of absorbance at 405 nm. The trends were similar to the results obtained by hemagglutination of inhibition assay. AsialoPSM required 8.2 ng to reach 1.5 absorbance at 405 nm, while PSM, asialoBSM, human glycophorin A, and BSM required 15.8 ng, 33.6 ng, 43.9 ng, and 60.2 ng respectively. Asialofetuin, fetuin, and 1-acid glycoprotein failed to yield 1.5 absorbance at more than 550 ng. These results indicate that LAG recognized O-linked sugar chains.
The glycoprotein inhibition profiles are shown in Fig. 5 . The results were expressed as quantity of glycoproteins (ng) giving 50% inhibition of control lectin binding, as summarized in Table 4 . AsialoPSM was the best inhibitor among the glycoproteins, and required 0.5 ng for 50% inhibition of LAG. PSM, human glycophorin A, asialoBSM, BSM, and asialofetuin required 1.6 ng, 4 ng, 6.2 ng, 20.6 ng, and 325 ng respectively. Fetuin and 1-acid glycoprotein gave 28% and 33% inhibition respectively at a concentration of 325 ng.
The amino acid composition of LAG is shown in Table 5 . No cysteine or high Asx was observed. The result is compatible with the values from LAG sequence. The peptide sequences of LAG, determined by automated Edman degradation, are shown in Fig. 6 . Con- Inhibitory activity was estimated from the inhibition curve (Fig. 3) . Fig. 3 . Inhibition Profiles of Interaction between Biotinylated LAG and Asialofetuin. LAG (6.25 ng) was preincubated with equal volumes of serially diluted sugars, and the mixtures were added to asialofetuin (250 ng/ 50 mL) coated microtiter plates. A 405 was recorded after 2 hincubation. The experiments were conducted in triplicate, and the results were expressed as mean values. , GalNAc1-3(Fuc1-2)Gal; , Fuc1-2Gal1-4Glc; , Gal1-4Glc; , Gal1-3Gal-NAc; , Gal1-3GalNAc1-Benzyl; , Gal1-4GlcNAc; , Gal1-4[Fu1-3]Glc; , PNP--GalNAc; þ, GalNAc; and À, Galactose. (Fig. 4) . 2 Quantity of glycoproteins estimated from the inhibition curve (Fig. 5) . struction of the whole sequence of LAG was not performed from the peptide sequences, because the overlap between peptides was insufficient. Peptides D and Try1 contain RVNWER, the residues of which are common to the carbohydrate recognition domain of galectins, and therefore LAG was judged to be a galectin. The whole sequence of LAG was constructed in comparison with the sequences of other fungal galectins. Two chymtryptic peptides were obtained for the sequence 134-144. The yield of CHY2 was only 25% of CHY1, suggesting that the major sequence of LAG has Phe at residue 141. Genomic DNA sequence containing the complete reading frame encoding the full length of LAG is shown in Fig. 7 . No intron was found in the genomic DNA. Five residues were different between the peptide sequences and the genomic sequences. N-terminal methionine was not found in LAG. The genomic DNA was assumed to be an isomer of LAG or a homology of galectin.
The molecular mass of LAG was calculated to be 17,585 (Fig. 6 ). This value was in accordance with the 17,589.55 obtained by MALDI-TOF-MS. The amino acid sequence of LAG indicated three possible Nglycosylation sites, NTS (residues 42-44), NTT (residues 96-98), and NGT (residues 127-129) in the molecule (Figs. 6, 7, and 8) . The calculated isoelectric point was 4.2, slightly different from the isoelectric point of LAL as determined experimentally.
2)

Discussion
In this study, LAG was purified from fruit bodies of Laccaria amethystina, but the lectin corresponding to LAF discovered by Guillot et al.
2) was not obtained. Likewise, Didier et al. 21) did not detect LAF in L. amethystina extract.
LAG exhibited binding to lactose and blood group A trisaccharide (Tables 2, 3, Fig. 3 ) and agglutinated erythrocytes of human blood groups A and O.
All the galectins recognized to a certain degree the basic structure Gal1-4GlcNAc, but affinity toward it varied considerably. 22) For most galectins, Gal1-4GlcNAc is a significantly more potent inhibitor than lactose. For CGL2, LacNAc is more potent than lactose. LAG, however, like rat intestine domain I, 23 ) Xenopus laevis, 24) and sponge sponge Geodia cydonium 25) lectins, preferred lactose to LaNAc. Unlike LAG and CGL2, 26) A. cylindracea galectin (ACG) 27) and rat intestine domain II galectin 23) binds lactose and N-acetyllactosamine at equal potency. Substitution of 3OH at the glucose of Gal1-4Glc greatly reduces the inhibitory potency of CGL2, and in most galectins it abolishes binding. In LAG, this substitution reduced affinity by 7-fold. According to Hirabayashi et al., 22) in a study of the oligosaccharide specificity of galectins by frontal affinity chromatography, disparities among the galectins examined become apparent. Among fungal galectins, the affinity of CGL2 26) toward disaccharides was as follows: LacNAc > T-antigen > lactose, the reverse of LAG.
In the hemagglutination-inhibition assay (Table 2) , ELLSA and inhibition assays of LAG showed high affinity to O-glycoproteins PSM, BSM, and their asialo counterparts (Table 4 , Figs. 4 and 5 ). Human glycophorin A was also a strong inhibitor. Mild acid hydrolysis, which removes the terminal neuraminic acids of glycoproteins PSM and BSM, slightly increases the binding affinity of LAG. Asialo PSM and asialoBSM generated enhancement in affinity with LAG by 3-fold over PSM and BSM, indicating that the high density of polyvalent Tn/T slightly improved the binding ability of LAG. Tn is a major carbohydrate chain in asialoBSM that accounts for 53% of total chains, and followed by T at 22%. 28) AsialoPSM has a little more exposed Tn than T, and the major carbohydrate chains of PSM (65%) are O-linked through GalNAc to the protein core. 29) Some of these are composed of blood A or H glycans. The presence of core 1 blood group type A saccharides can contribute to the high binding affinity of LAG towards human blood group A and PSM/asialo PSM. Gal1-3GalNAc-can contribute to the high affinity of LAG to O-linked glycoproteins. Fetuin and 1-acid glycoprotein were poor inhibitors due to the poor binding preference of LAG to LacNAc, and the relatively high affinity of asialo fetuin as compared to fetuin and 1-acid glycoprotein was probably due to exposure of the termini of both N-and O-linked oligosaccharides.
Although all galectins show affinity for -galactoside, various studies have indicated that each galectin has its own characteristic binding preferences. 22, 30, 31) Moreover, galectins can show a shift of binding specificity from one type of carbohydrate ligand to another when the surface density of the carbohydrates increases. 32) This hypothesis confirms that every lectin and galectin with a unique amino acid sequence has a different biological role. The affinity of LAG to O-linked glycoproteins indicates that it might be useful in the purification and analysis of O-linked glycoproteins as well as in the detection of both crypto and exposed Tn/T.
The complete amino acid sequence of 161 amino acid residues of LAG was established by sequencing of peptides fragments. The primary structure of LAG was compared with other fungal galectins and the galectin-like proteins characterized so far: L. bicolor, 11) C. cinereus, 3, 6) A. cylindracea, 4) and A. aegerita.
5)
Based on the results of sequence alignment using ClustalW and ClustalX version 2.0 multiple sequence alignment software by Larkin et al., 33) the structure showed overall amino acid sequence identity of 35.5% for Agrocybe galectins and 75.6% for L. bicolor. LAG, and other fungal galectins studied so far had an unmodified N-terminus, except for ACG. It is notable that LAG, like ACG and CGL1-3, has no cysteine residue, unlike L. bicolor galectins. to sugar binding of LAG is yet to be studied. Arg
83
(residue number in LAG), which is also involved in sugar binding, was not conserved in the genomic DNA sequence. In ACG 35) and CGL2, 26) the corresponding Arg did not form a hydrogen bond with lactose. In mammalian galectin 1, 36) Asn 46 (number in human galectin-1) also contributes to lactose binding through water-mediated interaction with 3-OH of lactose, but this residue is not conserved in LAG or in other fungal galectins characterized to date. In CGL1 and 2 and LBG1-3, Asn 46 is replaced by Ser, while in ACG, it is substituted by Ala (Fig. 8) . A crystallographic study of CGL2 26) indicated that the Ser residue has the role of mammalian galectin Asn 46 . As Fig. 6 shows, some fungal galectins, except for CGL1, 2, have a 5-9 residue insertion among residue 36-41 in LAG. In the insertion, Asn 46 in ACG (corresponding to residue 41 in LAG) forms a hydrogen bond with nonreducing 3OH of lactose. 35) Similarly, a hydrogen bond was reported for Asn 45 in the CGL3-chitooligosaccharide complex. 7) Thus fungal galectins have the characteristic sequences, and hence some amino acid residues, not in the typical CRD of galectin, might be involved in sugar binding. A comparison of the primary structure deduced from genomic DNA with the primary structure from the peptide sequence revealed the heterogeneity of LAG, as shown in Figs. 6, 7. These two slightly different amino acid sequences suggest that there are two or more structurally related genes. Those AAs were found at positions 75, 83, 86, 89, and 121. These results indicate that LAG, like other mushroom lectins from L. bicolor and C. cinereus, 37) occurs in several iso-forms derived from different genes. Heterogeneity is common for mushroom lectins, and might be a result of gene polymorphism or the presence of highly conserved multiple families encoding isolectins. In ACG, 5) some heterogeneity along the amino acid sequence was also identified, though corresponding genes have not yet been cloned.
The results of this study and previous studies of fungal galectins suggest that most fungal galectins occur in iso-forms. Further research is necessary to establish the other biological and biochemical characteristics of all the genes corresponding to the heterogeneity of LAG.
